Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy

NCT02012608 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Lack of funding/ PI leaving institution

Conditions

Breast Cancer

Interventions

DRUG: Glutamine
DRUG: Placebo

Sponsor

University of Arkansas